• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体液记忆何时增强感染?

When does humoral memory enhance infection?

机构信息

Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.

Department of Biology, Emory University, Atlanta, Georgia, United States of America.

出版信息

PLoS Comput Biol. 2023 Aug 21;19(8):e1011377. doi: 10.1371/journal.pcbi.1011377. eCollection 2023 Aug.

DOI:10.1371/journal.pcbi.1011377
PMID:37603552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10470880/
Abstract

Antibodies and humoral memory are key components of the adaptive immune system. We consider and computationally model mechanisms by which humoral memory present at baseline might increase rather than decrease infection load; we refer to this effect as EI-HM (enhancement of infection by humoral memory). We first consider antibody dependent enhancement (ADE) in which antibody enhances the growth of the pathogen, typically a virus, and typically at intermediate 'Goldilocks' levels of antibody. Our ADE model reproduces ADE in vitro and enhancement of infection in vivo from passive antibody transfer. But notably the simplest implementation of our ADE model never results in EI-HM. Adding complexity, by making the cross-reactive antibody much less neutralizing than the de novo generated antibody or by including a sufficiently strong non-antibody immune response, allows for ADE-mediated EI-HM. We next consider the possibility that cross-reactive memory causes EI-HM by crowding out a possibly superior de novo immune response. We show that, even without ADE, EI-HM can occur when the cross-reactive response is both less potent and 'directly' (i.e. independently of infection load) suppressive with regard to the de novo response. In this case adding a non-antibody immune response to our computational model greatly reduces or completely eliminates EI-HM, which suggests that 'crowding out' is unlikely to cause substantial EI-HM. Hence, our results provide examples in which simple models give qualitatively opposite results compared to models with plausible complexity. Our results may be helpful in interpreting and reconciling disparate experimental findings, especially from dengue, and for vaccination.

摘要

抗体和体液记忆是适应性免疫系统的关键组成部分。我们考虑并通过计算模型来研究基线时存在的体液记忆如何增加而不是降低感染负荷的机制;我们将这种效应称为 EI-HM(体液记忆增强感染)。我们首先考虑抗体依赖性增强(ADE),其中抗体增强病原体(通常是病毒)的生长,通常在抗体的中间“金发姑娘”水平。我们的 ADE 模型在体外重现了 ADE,并通过被动抗体转移增强了体内感染。但值得注意的是,我们的 ADE 模型的最简单实现从未导致 EI-HM。通过使交叉反应性抗体比新生成的抗体的中和能力低得多,或者通过包括足够强的非抗体免疫反应,增加复杂性,允许 ADE 介导的 EI-HM。接下来,我们考虑交叉反应性记忆通过排挤可能更优越的新生成免疫反应而导致 EI-HM 的可能性。我们表明,即使没有 ADE,当交叉反应性反应在针对新生成反应的强度和“直接”(即独立于感染负荷)抑制方面都较弱时,也会发生 EI-HM。在这种情况下,向我们的计算模型中添加非抗体免疫反应会大大降低或完全消除 EI-HM,这表明“排挤”不太可能导致实质性的 EI-HM。因此,我们的结果提供了与具有合理复杂性的模型相比,简单模型给出定性相反结果的示例。我们的结果可能有助于解释和协调来自登革热和疫苗接种等方面的不同实验结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/130310ed2a9b/pcbi.1011377.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/adfa959f95a8/pcbi.1011377.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/a3d8da4e8ede/pcbi.1011377.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/32c9ef13db00/pcbi.1011377.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/b0467cf0d30c/pcbi.1011377.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/5558c2ecaf91/pcbi.1011377.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/9b43cb68bb2f/pcbi.1011377.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/130310ed2a9b/pcbi.1011377.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/adfa959f95a8/pcbi.1011377.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/a3d8da4e8ede/pcbi.1011377.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/32c9ef13db00/pcbi.1011377.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/b0467cf0d30c/pcbi.1011377.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/5558c2ecaf91/pcbi.1011377.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/9b43cb68bb2f/pcbi.1011377.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1893/10470880/130310ed2a9b/pcbi.1011377.g007.jpg

相似文献

1
When does humoral memory enhance infection?体液记忆何时增强感染?
PLoS Comput Biol. 2023 Aug 21;19(8):e1011377. doi: 10.1371/journal.pcbi.1011377. eCollection 2023 Aug.
2
Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.母体抗体增强呼吸道合胞病毒感染并不能解释婴儿疾病的严重程度。
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00851-17. Print 2017 Nov 1.
3
Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.工程化登革病毒结构域 III 蛋白在小鼠中引发交叉中和抗体反应。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.01023-18. Print 2018 Sep 15.
4
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.抗体依赖性增强作用对登革热/寨卡病毒致病性的调节作用及寨卡病毒感染中预防增强作用的策略。
Front Immunol. 2018 Apr 23;9:597. doi: 10.3389/fimmu.2018.00597. eCollection 2018.
5
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.成人中乙脑疫苗促进的登革病毒感染增强抗体
BMC Infect Dis. 2016 Oct 18;16(1):578. doi: 10.1186/s12879-016-1873-8.
6
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.登革热和 Zika 病毒感染可被减毒活疫苗增强,但在小鼠模型中,重组 DSV4 候选疫苗不会增强登革热感染。
EBioMedicine. 2020 Oct;60:102991. doi: 10.1016/j.ebiom.2020.102991. Epub 2020 Sep 16.
7
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.抗体依赖增强作用:开发安全登革热疫苗的挑战。
Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020.
8
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
9
Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus.分子模拟揭示了抗体的精细特异性和病毒成熟状态在登革热病毒抗体依赖性增强感染中的作用。
Front Cell Infect Microbiol. 2019 Jun 6;9:200. doi: 10.3389/fcimb.2019.00200. eCollection 2019.
10
Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.登革病毒感染伴有高中和水平的交叉反应抗体,可导致小鼠急性致死性小肠病变,且小鼠体内病毒血症水平不高。
J Virol. 2015 Jun;89(11):5847-61. doi: 10.1128/JVI.00216-15. Epub 2015 Mar 18.

本文引用的文献

1
Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study.泰国中南部地区母婴登革热中和抗体的流行率和持久性:一项回顾性队列研究。
Asia Pac J Public Health. 2019 May;31(4):288-295. doi: 10.1177/1010539519853396.
2
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.登革热血清阳性状态对登革热疫苗安全性和有效性的影响。
N Engl J Med. 2018 Jul 26;379(4):327-340. doi: 10.1056/NEJMoa1800820. Epub 2018 Jun 13.
3
What Controls the Acute Viral Infection Following Yellow Fever Vaccination?
黄热病疫苗接种后急性病毒感染由何控制?
Bull Math Biol. 2018 Jan;80(1):46-63. doi: 10.1007/s11538-017-0365-3. Epub 2017 Nov 6.
4
Antibody-dependent enhancement of severe dengue disease in humans.抗体依赖增强作用在人类严重登革热疾病中的表现
Science. 2017 Nov 17;358(6365):929-932. doi: 10.1126/science.aan6836. Epub 2017 Nov 2.
5
From Original Antigenic Sin to the Universal Influenza Virus Vaccine.从原始抗原性失误到通用流感病毒疫苗。
Trends Immunol. 2018 Jan;39(1):70-79. doi: 10.1016/j.it.2017.08.003. Epub 2017 Aug 31.
6
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.赛诺菲巴斯德登革热疫苗的益处与风险:模拟优化部署
Science. 2016 Sep 2;353(6303):1033-1036. doi: 10.1126/science.aaf9590.
7
Dengue infection.登革热感染。
Nat Rev Dis Primers. 2016 Aug 18;2:16055. doi: 10.1038/nrdp.2016.55.
8
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses.抗体依赖性增强登革病毒感染原代人巨噬细胞;平衡更高的融合与抗病毒反应。
Sci Rep. 2016 Jul 6;6:29201. doi: 10.1038/srep29201.
9
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.使用异源HIV-1包膜序列和异源腺病毒载体进行疫苗接种可增强对保守区域的T细胞反应:HVTN 083。
J Infect Dis. 2016 Feb 15;213(4):541-50. doi: 10.1093/infdis/jiv496. Epub 2015 Oct 15.
10
WHO dengue case classification 2009 and its usefulness in practice: an expert consensus in the Americas.《2009年世界卫生组织登革热病例分类及其在实际中的效用:美洲地区专家共识》
Pathog Glob Health. 2015 Feb;109(1):19-25. doi: 10.1179/2047773215Y.0000000003. Epub 2015 Jan 28.